Skip to main content
Clinical Development Approaches and Statistical Methodologies to Prospectively Assess the Cardiovascular Risk of New Antidiabetic Therapies for Type 2 Diabetes
Comments on: “Some Challenges with Statistical Inference in Adaptive Designs”, by Hung, Wang, and Yang."
Aspirin Prophylaxis in Patients at Low Risk for Cardiovascular Disease: A Systematic Review of All Cause Mortality
StatXact 10 | Free 30-Day Trial